EDGAR Filing Documents for 0000000000-17-004532

Form UPLOAD - SEC-generated letter:

SEC Accession No. 0000000000-17-004532

Filing Date

2017-02-09

Accepted

2017-02-09 10:18:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.pdf	LETTER	31821
	Complete submission text file	0000000000-17-004532.txt		44659

Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087

Rasna Therapeutics Inc. (Filed for) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0331
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations